Paramedical Exam

A paramedical exam is a medical examination conducted by a licensed medical professional to gather health-related information about an individual applying for life or health insurance coverage. The exam is usually conducted at the applicant's home or workplace by a paramedic or nurse and may include collecting blood and urine samples, measuring vital signs, taking an electrocardiogram (EKG), and obtaining a medical history.

 

Here are some key features of a paramedical exam:

 

·      Purpose: The purpose of a paramedical exam is to assess the health status of an individual and provide important medical information to the insurance company so that they can evaluate the risk of insuring the individual.

 

·      Exam Components: The exam usually includes a physical exam, health questionnaire, and various medical tests, including blood and urine tests, and sometimes an EKG.

 

·      Convenience: The exam is conducted at the applicant's home or workplace, making it a convenient option for many people.

 

·      Importance: The results of the exam can have asignificant impact on the cost of insurance premiums and whether an applicantis approved for coverage.

 

·      Confidentiality: The medical informationcollected during the exam is kept confidential and is only shared with theinsurance company and those involved in underwriting and evaluating theapplication.

 

Overall, a paramedical exam is an important part of theinsurance underwriting process, helping insurance companies to assess thehealth risk of applicants and set premiums accordingly.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.